Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06564155
Inturlekin L33 in Ankylosing Spondylities Patients and Its Relation to Subclinical Atherosclerosis
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
detect level of Inturlekin 33 in ankylosing spondyilits patient measure CIMT (carotid intima media thickness ) by carotid duplex to detect subclinical atherosclerosis in ankylosing spondyitis patients detect the relation between IL33 and subclinical atherosclerosis in Ankylosinig Spondylitis patients
Official title: Inturlekin 33 in Ankylosing Spondylitis Patients and Its Relationship to Subclinical Atherosclerosis
Key Details
Gender
All
Age Range
20 Years - 40 Years
Study Type
OBSERVATIONAL
Enrollment
45
Start Date
2024-09
Completion Date
2026-12
Last Updated
2024-08-22
Healthy Volunteers
Yes
Conditions
Interventions
DEVICE
carotid duplex
measure Carotid intima media thickness